Viewing Study NCT02403258


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2025-12-25 @ 10:04 PM
Study NCT ID: NCT02403258
Status: UNKNOWN
Last Update Posted: 2018-02-22
First Post: 2015-03-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: The Effect and Safety of Plum-blossom Needle for Tourette Syndrome
Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Organization:

Study Overview

Official Title: The Effect and Safety of Plum-blossom Needle for Tourette Syndrome: a Randomized Controlled Trial
Status: UNKNOWN
Status Verified Date: 2018-02
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the effect and safety of plum-blossom needle for Tourette syndrome.
Detailed Description: This is a randomized, controlled trial with two parallel arms. A total of 60 patients will be randomly allocated into the plum-blossom needle group (n=30) and the habit reversal training (HRT) group (n=30). 12-week treatment will be given to all patients of each group, follow-up will be made at the 12th week after treatment. The primary outcome measure will be the mean change from baseline in the total tic score on the Yale Global Tic Severity Scale (YGTSS) at the 12th week. Secondary outcome measures will include the mean changes in score of YGTSS, TS Clinical Global Impression Scale (CGI) and the Children and Adolescents' Quality of Life Scale from baseline at other time. Safety will also be evaluated.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: